trending Market Intelligence /marketintelligence/en/news-insights/trending/FAgqjpb0D4iYfn_UjEOSHw2 content esgSubNav
In This List

MEI Pharma raises $51.8M from stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


MEI Pharma raises $51.8M from stock offering

MEI Pharma Inc. said it raised $51.8 million from a public offering of shares after underwriters exercised an option to buy additional stock.

The San Diego-based company closed the offering selling 32,343,750 shares at $1.60 apiece, including 4,218,750 shares as part of the underwriters' overallotment option.

MEI Pharma intends to use net proceeds to fund its clinical development programs and for general corporate purposes.

Stifel and Wells Fargo Securities were joint book-running managers for the offering.